JPRN-UMIN000012478招募中未知
Open label trial for efficacy and safety of Hydroxychloroquine for systemic lupus erythematosus - Hydroxychloroquine for systemic lupus erythematosus
Department of Internal Medicine, Teikyo University School of Medicine0 个研究点目标入组 10 人开始时间: 2014年1月1日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe insufficiency in liver, kidney, heart, bone marrow function. Patients with current or previous history of retinopathy. Patients allergic to 4-aminoquinoline. Other patients who were judged to be ineligible for the study by an attending physician.
研究者
相似试验
尚未招募
不适用
International study in multiple centers studying the effect of hydroxy-urea and temozolomide chemotherapy in patients with a recurrent malignant brain tumor (Glioblastoma)Brain tumor, glioma, glioblastoma, recurrent glioblastoma, glioblastoma multiformeHersentumor, glioom, glioblastoom, recidief glioblastoom, glioblastoma multiformeNL-OMON20720VU University Medical Center35
已完成
不适用
International Multicenter Phase I trial of Hydroxyurea in Combination with Dose-Intense Temozolomide in Recurrent Glioblastoma.High grade glioma10029211brain tumorNL-OMON50467Vrije Universiteit Medisch Centrum49
招募中
3 期
Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N51Sina Darou Laboratories Company80
已完成
3 期
Hydroxychloroquine prophylaxis in preventing the severe forms of Covid-19IRCT20200421047153N1Islamic Azad University1,000
已完成
3 期
An open label clinical trial of an orally-dosed herbal formulation Zinova (Registered Trademark) for the prevention of dysmenorrhoea (menstrual pain).DysmenorrhoeaAlternative and Complementary Medicine - Herbal remediesReproductive Health and Childbirth - Menstruation and menopauseACTRN12612000149864Applied Science and Nutrition Pty. Ltd.20